Kuyoung Chung is an Investment Committee member for Taranis Capital's BioTech Growth Fund. He is a Managing Director driving healthcare venture creation and digital strategy.

He is an expert in AI commercialisation with three patents and ten publications, having led innovation programmes for Samsung and LG. His expertise combines deep R&D capabilities, M&A due diligence, and global partnership strategy.

Kuyoung holds an MBA from IMD Business School and is an ETH Zurich alumnus.